Insulin Glargine and Lixisenatide Injection（Ⅱ）

SANOFI WINTHROP INDUSTRIE🇨🇳 National Medical Products Administration

Approval Id: a95e53fc0cf0668b
Approval Number: 国药准字SJ20230002
Generic Name: 甘精胰岛素利司那肽注射液(Ⅱ)
Generic Name En: Insulin Glargine and Lixisenatide Injection（Ⅱ）
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 预填充笔，3ml：300单位甘精胰岛素 + 150 μg利司那肽
Reg Date: 2023-01-10
Expired Date: 2028-01-09
Company Name: SANOFI WINTHROP INDUSTRIE
Production Company Name: Sanofi-Aventis Deutschland Gmbh
Company Detail Path: /organization/sanofi-winthrop-industrie
Production Company Detail Path: /organization/sanofi-aventis-deutschland-gmbh

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 10, 2023

Approval ID

a95e53fc0cf0668b

Type

生物制品